机构:[1]Capital Med Univ, Xuanwu Hosp, Beijing Key Lab Hypoxia Translat Med, Beijing, Peoples R China首都医科大学宣武医院[2]Capital Med Univ, Beijing Inst Brain Disorder, Ctr Stroke, Beijing 100053, Peoples R China[3]Capital Med Univ, Hypoxia Conditioning Translat Lab Clin Med, Beijing, Peoples R China[4]Beijing Univ Chines Med, Sch Chinese Med, Beijing 100029, Peoples R China[5]Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Neurosurg, Beijing, Peoples R China[6]Chinese Peoples Liberat Army Gen Hosp, Chinese PLA Med Sch, Beijing, Peoples R China[7]Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Neurosurg, Beijing, Peoples R China
Cholinergic cells originating from the medial septal nucleus (MS) and the vertical and horizontal limbs of the diagonal band of Broca (VDB and HDB, respectively) are critical for supporting a variety of memory and cognitive functions. However, the viability of cholinergic cells has not been explored in the context of acute hypoxia (AH). This study aimed to investigate the effects of AH on cholinergic cells in these nuclei and to test whether hypoxic preconditioning (HPC)-a previously established neuroprotective therapy-could prevent cholinergic cell loss, cognitive dysfunction, and hippocampal synaptic dysfunction in mice exposed to AH. We found that cholinergic cell loss occurred in the MS/DB after AH. HPC prevented this effect and also improved AH-induced cognitive dysfunction and hippocampal synaptic dysfunction. Overall, our findings highlight the significant role of cholinergic cells in AH-induced memory impairments and suggest that the preservation of cholinergic cell viability may provide a mechanism by which HPC improves memory impairments and preserves the function of memory-processing brain structures after AH.
基金:
The 2030-Major Research Project on the Prevention and Treatment of Cancer, Cardiovascular and Cerebrovascular Diseases, Respiratory Diseases, and Metabolic Diseases [2023ZD 0505305]; National key research and development program [2022YFC3602401, 2022YFC350100]; National Natural Science Foundation of China [82274401, 82371305, 82172021]; Beijing Natural Science Foundation-Haidian Original Innovation Joint Foundation [L232134]
第一作者机构:[1]Capital Med Univ, Xuanwu Hosp, Beijing Key Lab Hypoxia Translat Med, Beijing, Peoples R China[2]Capital Med Univ, Beijing Inst Brain Disorder, Ctr Stroke, Beijing 100053, Peoples R China[3]Capital Med Univ, Hypoxia Conditioning Translat Lab Clin Med, Beijing, Peoples R China
通讯作者:
通讯机构:[1]Capital Med Univ, Xuanwu Hosp, Beijing Key Lab Hypoxia Translat Med, Beijing, Peoples R China[2]Capital Med Univ, Beijing Inst Brain Disorder, Ctr Stroke, Beijing 100053, Peoples R China[3]Capital Med Univ, Hypoxia Conditioning Translat Lab Clin Med, Beijing, Peoples R China[5]Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Neurosurg, Beijing, Peoples R China[7]Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Neurosurg, Beijing, Peoples R China[*1]Capital Med Univ, Xuanwu Hosp, Beijing, Peoples R China[*2]Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Qin Linhui,Yang Yong,Zhang Houdi,et al.Hypoxic Preconditioning Mitigates Acute Hypoxia Induced MS/VDB Cholinergic Cell Loss and Memory Impairments[J].AGING AND DISEASE.2025,doi:10.14336/AD.2025.0175.
APA:
Qin, Linhui,Yang, Yong,Zhang, Houdi,Li, Sijie,Wu, Xi...&Ren, Changhong.(2025).Hypoxic Preconditioning Mitigates Acute Hypoxia Induced MS/VDB Cholinergic Cell Loss and Memory Impairments.AGING AND DISEASE,,
MLA:
Qin, Linhui,et al."Hypoxic Preconditioning Mitigates Acute Hypoxia Induced MS/VDB Cholinergic Cell Loss and Memory Impairments".AGING AND DISEASE .(2025)